Up 810% in a year, the Mesoblast share price is surging again on Monday. Here's why
Investors are piling into Mesoblast shares on Monday. But why? The post Up 810% in a year, the Mesoblast share price is ...
Why Appen, Mesoblast, Rio Tinto, and Woodside shares are falling today
These shares are falling more than most on Thursday. But why? The post Why Appen, Mesoblast, Rio Tinto, and Woodside shares ...
While Mesoblast (ASX:MSB) shareholders have made 667% in 1 year, increasing losses might now be front of mind as stock sheds 8.7% this week
Mesoblast Limited ( ASX:MSB ) shareholders might be concerned after seeing the share price drop 27% in the last ...
Mesoblast Sets Ryoncil® Price Based on Economic Value of Treatment With Planned Product Availability This Quarter
Manufacturing: As a result of FDA approval of RYONCIL in December 2024, the US$23.0 million provision against the value of inventory manufactured and expensed in prior periods was reversed and is now ...
Jefferies Keeps Their Hold Rating on Mesoblast Limited (MEOBF)
In a report released today, David Stanton from Jefferies maintained a Hold rating on Mesoblast Limited (MEOBF – Research Report), with a price ...
Mesoblast (MESO) to Release Quarterly Earnings on Thursday
Mesoblast (NASDAQ:MESO – Get Free Report) is anticipated to announce its earnings results on Thursday, February 27th.
APRA targets boards; Cyclone Alfred intensifies; Trump’s chain reaction
In today’s news, APRA’s new rules target bank and super boards, the Gold Coast records its “highest ever” wave as Cyclone Alfred barrels in, and Donald Trump sets off a chain reaction across global ...
Benzinga.com8d
Mesoblast Stock Price, Quotes and Forecasts
Explore Mesoblast stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for MESO.
Yahoo Finance8d
Mesoblast Sets Ryoncil® Price Based on Economic Value of Treatment With Planned Product Availability This Quarter
NEW YORK, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today provided financial results and ...
Motley Fool Australia3d
Up 810% in a year, the Mesoblast share price is surging again on Monday. Here's why
Learn More The Mesoblast Ltd (ASX: MSB) share price is racing higher today. Again. Shares in the (as of now) S&P/ASX 300 Index (ASX: XKO) clinical-stage biotechnology company closed on Friday ...